Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000389449 | SCV000472717 | uncertain significance | Farber lipogranulomatosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001289242 | SCV001476927 | likely benign | not provided | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001289242 | SCV002360385 | likely benign | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002523652 | SCV003549454 | uncertain significance | Inborn genetic diseases | 2021-10-19 | criteria provided, single submitter | clinical testing | The c.504-4A>G intronic alteration consists of a A to G substitution 4 nucleotides before exon 8 of the ASAH1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |